Company page

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics, Inc. (ticker: CVKD) is a public company based in the United States with a market capitalization of approximately $10 million. The company focuses on developing innovative therapies to address unmet medical needs. Cadrenal aims to improve patient outcomes through its specialized treatment approaches in the healthcare sector.